Hormone signaling via androgen receptor affects breast cancer and prostate cancer in a male patient: A case report

Abstract Background Male breast cancer (MBC) is rare, accounting for only around 1% of all breast cancers. Most MBCs are hormone-driven. Not only the estrogen receptor (ER), but also other steroid hormone receptors, including the androgen receptor (AR) and progesterone receptor (PgR) are expressed i...

Full description

Bibliographic Details
Main Authors: Haruko Takuwa, Wakako Tsuji, Masayuki Shintaku, Fumiaki Yotsumoto
Format: Article
Language:English
Published: BMC 2018-12-01
Series:BMC Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12885-018-5216-6